Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats

Biochemical and Biophysical Research Communications

Volumn 368, Issue 3, 2008, Pages 528-535

  Portero Otín, Manuel ^a   Pamplona, Reinald ^a   Boada, Jordi ^a   Jové, Mariona ^a   Gonzalo, Hugo ^a   Buleon, Marie ^b   Linz, Wolfgang ^c   Schäfer, Stefan ^c   Tack, Ivan ^b   Girolami, Jean Pierre ^b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b Inst Natl de la Sante et de la R   (France)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Advanced glycated end products; Angiotensin converting enzyme inhibitor; AT1 receptor antagonist; AVE7688; Diabetic nephropathy; Lipoxidation; Losartan; Protein oxidation; Ramipril; Vasopeptidase inhibition; Zucker diabetic fatty acid rats

Indexed keywords

2,4 DINITROPHENOL; 6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; AMINOADIPIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AVE 7688; CARBONYL DERIVATIVE; CELL PROTEIN; GLUTAMIC ACID; LOSARTAN; LYSINE DERIVATIVE; MALONALDEHYDE; PLACEBO; RAMIPRIL; UNCLASSIFIED DRUG; VASOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MARKER; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; INHIBITION KINETICS; LIPID COMPOSITION; MASS SPECTROMETRY; MEASUREMENT; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINALYSIS; ZUCKER DIABETIC FATTY RAT;

RATTUS;

EID: 39749083238     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.101     Document Type: Article

References (20)

1. P.A. McCullough G.L. Bakris W.F. Owen Jr. P.S. Klassen R.M. Califf Slowing the progression of diabetic nephropathy and its cardiovascular consequences Am. Heart J. 148 2004 243 251
2. N. Tanji G.S. Markowitz C. Fu T. Kislinger A. Taguchi M. Pischetsrieder D. Stern A.M. Schmidt V.D. D’Agati Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease J. Am. Soc. Nephrol. 11 2000 1656 1666
3. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
4. G. Jerums S. Panagiotopoulos J. Forbes T. Osicka M. Cooper Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease Arch. Biochem. Biophys. 419 2003 55 62
5. H.B. Lee M.R. Yu Y. Yang Z. Jiang H. Ha Reactive oxygen species-regulated signaling pathways in diabetic nephropathy J. Am. Soc. Nephrol. 14 2003 S241 S245
6. B.J. Davis C.I. Johnston L.M. Burrell W.C. Burns E. Kubota Z. Cao M.E. Cooper T.J. Allen Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy Diabetologia 46 2003 961 971
7. S. Schafer W. Linz A. Bube M. Gerl J. Huber G.U. Kurzel M. Bleich H.L. Schmidts A.E. Busch H. Rutten Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats Cardiovasc. Res. 60 2003 447 454
8. S. Schafer W. Linz H. Vollert G. Biemer-Daub H. Rutten M. Bleich A.E. Busch The vasopeptidase inhibitor AVE7688 ameliorates type 2 diabetic nephropathy Diabetologia 47 2004 98 103
9. S. Schafer H.L. Schmidts M. Bleich A.E. Busch W. Linz Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent Br. J. Pharmacol. 143 2004 27 32
10. C. Wihler S. Schafer K. Schmid E.K. Deemer G. Munch M. Bleich A.E. Busch T. Dingermann V. Somoza J.W. Baynes J. Huber Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition Diabetologia 48 2005 1645 1653
11. J. Allard M. Buleon E. Cellier I.M. Renaud C. Pecher F. Praddaude M. Conti I. Tack J.P. Girolami ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats Am. J. Physiol. Renal Physiol. 293 2007 F1083 F1092
12. R. Couture J.P. Girolami Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus Eur. J. Pharmacol. 500 2004 467 485
13. G. Nickenig D.G. Harrison The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis Circulation 105 2002 393 396
14. J.M. Forbes M.E. Cooper V. Thallas W.C. Burns M.C. Thomas G.C. Brammar F. Lee S.L. Grant L.A. Burrell G. Jerums T.M. Osicka Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy Diabetes 51 2002 3274 3282
15. M. Nangaku T. Miyata T. Sada M. Mizuno R. Inagi Y. Ueda N. Ishikawa H. Yuzawa H. Koike C. van Ypersele de Strihou K. Kurokawa Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model J. Am. Soc. Nephrol. 14 2003 1212 1222
16. G. Cao R.G. Cutler Protein oxidation and aging. I. Difficulties in measuring reactive protein carbonyls in tissues using 2,4-dinitrophenylhydrazine Arch. Biochem. Biophys. 320 1995 106 114
17. J.R. Requena C.C. Chao R.L. Levine E.R. Stadtman ER Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins Proc. Natl. Acad. Sci. USA 98 2001 69 74
18. A.V. Cantero M. Portero-Otin V. Ayala N. Auge M. Sanson M. Elbaz J.C. Thiers R. Pamplona R. Salvayre A. Negre-Salvayre Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis FASEB J. 21 2007 3096 3106
19. R. Pamplona E. Dalfo V. Ayala M.J. Bellmunt J. Prat I. Ferrer M. Portero-Otin Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets J. Biol. Chem. 280 2005 21522 21530
20. J.P. Cosgrove D.F. Church W.A. Pryor The kinetics of the autoxidation of polyunsaturated fatty acids Lipids 22 1987 299 304